熔点	36-43 ºC
沸点	260-263 ºC (4 torr)

危险品标志	Xn
危险类别码	R20/21/22
安全说明书	S24/25

来源	SDS样本
Alfa-Aesar	浏览或下载
Sigma-Aldrich	浏览或下载
TCI	浏览或下载

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Torsemide: a new loop diuretic.S F Fowler et al.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 52(16), 1771-1780 (1995-08-15) Loop diuretics: comparison of torsemide, furosemide, and bumetanide.B P Chen Connecticut medicine, 60(6), 343-345 (1996-06-01) Could torasemide be a prophylactic agent of contrast induced acute kidney injury? A review about this field.X-M Li et al.European review for medical and pharmacological sciences, 17(14), 1845-1849 (2013-07-24) TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.Javier Díez et al.Expert review of cardiovascular therapy, 7(8), 897-904 (2009-08-14) [Possibilities of the use of torasemide in clinical practice].A G Evdokimova et al.Kardiologiia, 52(12), 84-89 (2012-12-15) Torsemide: a pyridine-sulfonylurea loop diuretic.J S Blose et al.The Annals of pharmacotherapy, 29(4), 396-402 (1995-04-01) [A new case of nevus oligemicus].Leticia Sempau et al.Dermatology online journal, 16(8), 16-16 (2010-09-02) Torasemide prolonged release.Katherine A Lyseng-Williamson Drugs, 69(10), 1363-1372 (2009-07-09) Anti-albuminuric effects of the angiotensin AT1 receptor blocker telmisartan in hypertensive patients.José C Rodríguez-Pérez et al.Clinical and experimental hypertension (New York, N.Y. : 1993), 33(8), 506-510 (2011-10-01) Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study. Clinical therapeutics, 33(9), 1204-1213 (2011-09-13) Determination of torasemide by fluorescence quenching method with some dihalogenated fluorescein dyes as probes.Zhiping Cui et al.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 114, 547-552 (2013-06-25) [Etiologies of nephrotic syndrome].S Heeringa et al.Praxis, 100(9), 505-514 (2011-04-29) Agents with antialdosterone properties should be the preferred diuretics for reducing hypertension related atrial fibrillation.Oscar M P Jolobe European journal of internal medicine, 21(1), 55-55 (2010-02-04) Study on the interaction between torasemide and 12-tungstophosphoric acid by resonance Rayleigh scattering and resonance nonlinear scattering spectra and its analytical applications.Cuixia Li et al.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 79(5), 1084-1090 (2011-06-11) [Treatment of nephritic edema by torasemide in children].Qi Li et al.Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 13(6), 520-521 (2011-06-16) Should torsemide be the loop diuretic of choice in systolic heart failure?James J DiNicolantonio Future cardiology, 8(5), 707-728 (2012-09-28) [Postpartum cardiomyopathy].J Strobel et al.Deutsche medizinische Wochenschrift (1946), 136(22), 1207-1210 (2011-05-26) Use of the loop diuretic torsemide in three dogs with advanced heart failure.Mark A Oyama et al.Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology, 13(4), 287-292 (2011-10-28) Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?Behnood Bikdeli et al.Journal of the American College of Cardiology, 61(14), 1549-1550 (2013-03-19) The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction.Sanjay Gupta et al.European journal of heart failure, 12(7), 746-752 (2010-06-08) Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease.Gordon D Peddle et al.Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology, 14(1), 253-259 (2012-03-01) [Torasemide is the effective loop diuretic for long-term therapy of arterial hypertension].D V Preobrazhenskiĭ et al.Kardiologiia, 51(4), 67-73 (2011-06-01) Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy?Robert J MacFadyen et al.European journal of heart failure, 12(7), 649-652 (2010-06-26) A bioavailability/bioequivalence and pharmacokinetic study of two oral doses of torasemide (5 and 10 mg): prolonged-release versus the conventional formulation.M J Barbanoj et al.Clinical and experimental pharmacology & physiology, 36(5-6), 469-477 (2009-08-14) [Update: prolonged-release torasemide].Carmen Acuña Drugs of today (Barcelona, Spain : 1998), 46 Suppl E, 1-15 (2010-10-12) Gender is an important determinant of the disposition of the loop diuretic torasemide.Ulrike Werner et al.Journal of clinical pharmacology, 50(2), 160-168 (2009-11-26) Drug-induced photodermatitis in elderly nursing home residents.Aikaterini I Liakou et al.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 9(8), 631-632 (2011-02-18) [Frequent drug interactions in old age].C C Wagner et al.Praxis, 98(21), 1185-1190 (2009-10-22) Chemometrically assisted development and validation of LC-UV and LC-MS methods for simultaneous determination of torasemide and its impurities.Zarko Jovic et al.Journal of chromatographic science, 50(4), 324-334 (2012-03-13) Reversed-phase ultra-performance liquid chromatographic method development and validation for determination of impurities related to torsemide tablets.Hitesh B Patel et al.Journal of AOAC International, 94(1), 143-149 (2011-03-12)

备注